Endovascular Treatment of Chronic Intracranial Artery Occlusion

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

About this trial

Comparison of the efficacy and safety of endovascular treatment versus medical treatment in patients with chronic intracranial artery occlusion.

Eligibility criteria

Qualifiers

Age ≥18 years

Occlusion of the unilateral middle cerebral artery, basilar artery, intracranial internal carotid artery, or vertebral artery, as confirmed by computed tomography angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA)

Modified Rankin Scale (mRS) score of 0-2

Presence of symptoms related to the occluded vessel, as determined by the physician, with the most recent symptom onset occurring more than 4 weeks and within 6 months prior to enrolment

Disqualifiers

Evidence of hemorrhage on CT or MRI

Large hemispheric infarction involving >50% of the middle cerebral artery territory on CT or MRI

Severe pre-stroke disability (modified Rankin Scale score ≥2) or life expectancy <12 months

Major comorbidities that may interfere with outcome assessment and follow-up (e.g., severe heart failure, renal failure, etc.)

Trial design

Treatments tested in this trial

  • Endovascular treatment
  • Standard pharmacological treatment

Treatment groups

382 Participants
are divided into 2 treatment groups

Locations

This trial has no locations